REGN - REGENERON PHARMACEUTICALS, INC.
766.66
-24.150 -3.150%
Share volume: 636,991
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$790.81
-24.15
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 10-31-2024 | 02-05-2025 | 04-29-2025 | 08-01-2025 | 10-28-2025 | 02-04-2026 | |
| Total revenue | 3.145 B | 3.547 B | 3.721 B | 3.789 B | 3.029 B | 3.676 B | 3.754 B | 3.884 B | |
| Cost of revenue | 240.400 M | 257.800 M | 491.100 M | 565.400 M | 464.300 M | 530.200 M | 521.600 M | 584.600 M | |
| Gross profit | 2.905 B | 3.289 B | 3.230 B | 3.224 B | 2.564 B | 3.145 B | 3.233 B | 3.300 B | |
| 13.24% | -1.81% | -0.18% | -20.45% | 22.66% | 2.78% | 2.07% | |||
| Operating expenses | 1.937 B | 1.959 B | 2.042 B | 2.218 B | 1.973 B | 2.066 B | 2.216 B | 2.420 B | |
| Selling general and admin | 689.000 M | 758.800 M | 714.400 M | 792.200 M | 633.000 M | 634.200 M | 657.800 M | 775.000 M | |
| Research and development | 1.248 B | 1.200 B | 1.328 B | 1.426 B | 1.340 B | 1.432 B | 1.558 B | 1.645 B | |
| Total expenses | 2.371 B | 2.439 B | 2.050 B | 2.234 B | 1.973 B | 2.066 B | 2.206 B | 2.420 B | |
| 2.86% | -15.95% | 8.95% | -11.68% | 4.72% | 6.78% | 9.70% | |||
| Operating income | 773.800 M | 1.108 B | 1.180 B | 990.200 M | 591.700 M | 1.080 B | 1.027 B | 879.900 M | |
| Ebit | 773.800 M | 1.108 B | 1.507 B | 968.600 M | 913.700 M | 1.522 B | 1.783 B | 1.056 B | |
| Pretax income | 700.700 M | 1.628 B | 1.493 B | 958.100 M | 905.000 M | 1.519 B | 1.763 B | 1.044 B | |
| 132.35% | -8.30% | -35.83% | -5.54% | 67.81% | 16.11% | -40.81% | |||
| Income tax | -21.300 M | 195.800 M | 152.400 M | 40.400 M | 96.300 M | 127.100 M | 303.300 M | 199.100 M | |
| Net income basic | 722.000 M | 1.432 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 98.38% | -100.00% | ||||||||
| Net income | 722.000 M | 1.432 B | 1.341 B | 917.700 M | 808.700 M | 1.392 B | 1.460 B | 844.600 M | |
| 98.38% | -6.40% | -31.55% | -11.88% | 72.08% | 4.92% | -42.15% |